Add time:08/23/2019 Source:sciencedirect.com
1.1. We investigated the effects of short- and long-term administration of Efonidipine Hydrochloride (cas 111011-79-1) (NZ-105), 1,4-dihydropyridine derivative, in conscious spontaneously hypertensive rats (SHR).2.2. Oral administration of NZ-105 for 12 weeks caused diuretic and natriuretic effects, which were not attenuated during the experimental period.3.3. In the short-term experiment for investigating the mechanism of the diuretic effect, intravenous injection of NZ-105 (0.03 mg/kg of body weight) significantly increased the urine volume (UV), renal plasma flow (RPF) and glomerular filtration rate (GFR). The increment rate of UV and RPF was 105.4 ± 17.8% and 111.7 ± 72.8%, respectively, which were larger than the increment rate of GFR (38.5 ± 14.0%).4.4. The diuretic or natriuretic effect of NZ-105 was suggested to be due to both the inhibition of sodium reabsorption and, at least in part, the increase of GFR.
We also recommend Trading Suppliers and Manufacturers of Efonidipine Hydrochloride (cas 111011-79-1). Pls Click Website Link as below: cas 111011-79-1 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View